Invesco Biotechnology & Genome ETF (NY:PBE)
Price and Volume
Detailed Quote| Volume | 605 |
| Open | 94.96 |
| Bid (Size) | 95.01 (400) |
| Ask (Size) | 95.19 (100) |
| Prev. Close | 95.07 |
| Today's Range | 94.96 - 95.18 |
| 52wk Range | 70.01 - 98.82 |
| Shares Outstanding | 34,500 |
| Dividend Yield | 0.08% |
Top News
More News
Performance
52-Week Range
3.7% below 52-week high
95.18
70.0152W Low
98.8252W High
1 Week
2.9% below 1-week high
94.621W Low
98.001W High
Invesco Biotechnology & Genome ETF (PBE) traded between $70.01 and $98.82 over the past 52 weeks and last traded at $95.18, 3.7% below its 52-week high. Over the past week it ranged between $94.62 and $98.00.
Past 12 Months
-2.2%
-2.5%
+3.5%
+20.7%
+15.6%
+31.2%
1W
-$2.11
1M
-$2.46
3M
+$3.22
6M
+$16.33
YTD
+$12.83
1Y
+$22.62
PBE was +31.2% over the past year, +20.7% over six months, +15.6% year to date, -2.2% in the last week.
12 Months vs Market
PBE
+31.2%
DIA
+9.3%
SPY
+15.1%
QQQ
+24.0%
IWM
+14.5%
Over the past 12 months PBE returned +31.2% versus DIA (Dow) +9.3%, SPY (S&P 500) +15.1%, QQQ (Nasdaq 100) +24.0% and IWM (Russell 2000) +14.5%.
Volume & Liquidity
0.02× 3-mo avg
Today 605
3-mo avg 28.0K
1W
15.0K
1M
13.3K
3M
28.0K
6M
17.1K
YTD
14.0K
1Y
12.0K
PBE most recently traded 605 shares against a 3-month average daily volume of 28.0K.
More News
Read More
Via The Motley Fool
Topics
ETFs
IBBQ vs. PBE: Which Biotech ETF Is the Better Buy? ↗
August 21, 2026
Via The Motley Fool
Topics
ETFs
VanEck Pharmaceutical ETF vs. Invesco Biotech ETF: Which Fund Fits Your Investing Style? ↗
August 12, 2026
Via The Motley Fool
Topics
ETFs
XLV vs PBE: Is a Low-Cost Healthcare ETF the Better Buy Than a Focused Biotech Specialist? ↗
August 01, 2026
Via The Motley Fool
Topics
ETFs
VHT vs. PBE: Which Health Care ETF Is the Better Buy? ↗
July 30, 2026
Via The Motley Fool
Topics
ETFs
Why Did MNKD Stock Jump Over 7% In Pre-Market Today? ↗
January 26, 2026
Via Stocktwits
Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk ↗
September 29, 2025
3 Biotech Stocks to Buy That Have CRISPR-Like Breakthrough Potential ↗
February 19, 2024
Via InvestorPlace
US Judge Weighs Nationwide Ban On Abortion Pills ↗
March 16, 2023
Via Benzinga
7 Best Biotech Stocks to Buy in July 2022 ↗
July 08, 2022
Via InvestorPlace
Biotech ETFs That Outperformed Last Week ↗
December 20, 2021
Via Talk Markets
A Comprehensive Guide To Genomic ETFs ↗
July 11, 2021
Via Talk Markets
5 Top ETFs With Exposure To Biogen ↗
June 07, 2021
Via Talk Markets
5 Top ETFs With Exposure To Biogen ↗
June 07, 2021
Via Benzinga
Frequently Asked Questions
Is Invesco Biotechnology & Genome ETF publicly traded?
Yes, Invesco Biotechnology & Genome ETF is publicly traded.
What exchange does Invesco Biotechnology & Genome ETF trade on?
Invesco Biotechnology & Genome ETF trades on the New York Stock Exchange
What is the ticker symbol for Invesco Biotechnology & Genome ETF?
The ticker symbol for Invesco Biotechnology & Genome ETF is PBE on the New York Stock Exchange
What is the current price of Invesco Biotechnology & Genome ETF?
The current price of Invesco Biotechnology & Genome ETF is 95.18
When was Invesco Biotechnology & Genome ETF last traded?
The last trade of Invesco Biotechnology & Genome ETF was at 10/05/26 10:08 AM ET
What is the market capitalization of Invesco Biotechnology & Genome ETF?
The market capitalization of Invesco Biotechnology & Genome ETF is 3.28M
How many shares of Invesco Biotechnology & Genome ETF are outstanding?
Invesco Biotechnology & Genome ETF has 3M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>